CH
BLU

Canton Hathaway’s BELLUS Health Inc. BLU Stock Holding History

Canton Hathaway’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,000
Closed -$8K – 334
2021
Q1 		$8K Buy
+2,000
New +$7.59K ﹤0.01% 252

Other funds holding BLU

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Canton Hathaway's BLU Position: Q2 2021 in Review

Canton Hathaway sold out of BELLUS Health Inc. (BLU) in Q2 2021, closing a stake of 2,000 shares — an estimated $8K sold.

Canton Hathaway first reported a position in BLU in Q1 2021 and held it in 1 quarter. The position peaked at $8K in Q1 2021. 49 funds tracked by Wall St. Rank hold BLU as of Q2 2021.

  • Canton Hathaway reported no remaining BELLUS Health Inc. position as of Q2 2021 after selling out during the quarter.
  • Canton Hathaway sold 2,000 BELLUS Health Inc. shares in Q2 2021, an estimated $8K.
  • Canton Hathaway first reported a position in BELLUS Health Inc. in Q1 2021 and held it in 1 quarter.
  • Canton Hathaway's BELLUS Health Inc. position peaked at $8K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2021.

Based on Canton Hathaway's 13F filing for Q2 2021, filed 8 Jul 2021.